# Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum

> **NCT01761123** · PHASE1 · COMPLETED · sponsor: **Vaxart** · enrollment: 37 (actual)

## Conditions studied

- Seasonal Influenza

## Interventions

- **BIOLOGICAL:** VXA-A1.1

## Key facts

- **NCT ID:** NCT01761123
- **Lead sponsor:** Vaxart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2014-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761123, "Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01761123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*